Jiang, Chunling <br/><br/>
A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma.  [electronic resource] 

 -  Cancer  04 2019 
 - 1081-1090 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.31907  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--adverse effects<br/>Bifidobacterium longum<br/>Chemoradiotherapy--adverse effects<br/>Cisplatin--adverse effects<br/>DNA, Bacterial--analysis<br/>Double-Blind Method<br/>Enterococcus faecium<br/>Female<br/>Gastrointestinal Microbiome--genetics<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>Lactobacillus<br/>Male<br/>Middle Aged<br/>Nasopharyngeal Carcinoma--therapy<br/>Nasopharyngeal Neoplasms--therapy<br/>Probiotics--therapeutic use<br/>Radiotherapy, Intensity-Modulated--adverse effects<br/>Sequence Analysis, DNA<br/>Severity of Illness Index<br/>Stomatitis--prevention & control